Boston Family Office’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,850
| Closed | -$203K | – | 274 |
|
|
2022
Q1 | $203K | Hold |
2,850
| – | – | 0.01% | 283 |
|
|
2021
Q4 | $213K | Buy |
+2,850
| New | +$213K | 0.01% | 272 |
|
|
2019
Q3 | – | Sell |
-2,750
| Closed | -$232K | – | 256 |
|
|
2019
Q2 | $232K | Hold |
2,750
| – | – | 0.02% | 243 |
|
|
2019
Q1 | $263K | Buy |
+2,750
| New | +$263K | 0.03% | 230 |
|
|
2018
Q4 | – | Sell |
-2,750
| Closed | -$235K | – | 252 |
|
|
2018
Q3 | $235K | Hold |
2,750
| – | – | 0.02% | 245 |
|
|
2018
Q2 | $319K | Hold |
2,750
| – | – | 0.04% | 227 |
|
|
2018
Q1 | $223K | Buy |
+2,750
| New | +$223K | 0.03% | 248 |
|